APA Monitor on Psychology
Today’s newer TMS technologies can reach more deeply into the brain, and updated protocols are shrinking treatment times from weeks to days. TMS has also been extended to other conditions beyond depression in adults. The therapy is now approved for obsessive-compulsive disorder (OCD), migraines, and smoking cessation, and in 2024 it was cleared as an adjunctive treatment for depression in adolescents starting at age 15. Meanwhile, researchers are exploring TMS as a tool in other mental health disorders, such as eating disorders and post-traumatic stress disorder (PTSD), and even in neurological conditions such as mild cognitive impairment, Alzheimer’s disease, and autism.